ANNA WORKMAN: Open Payments
NPI 1225869548 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 32 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $108 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $120 |
| GENZYME CORPORATION | 3 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $63 |
| Janssen Biotech, Inc. | 3 | $60 |
| Ardelyx, Inc. | 2 | $55 |
| ABBVIE INC. | 3 | $55 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| Novo Nordisk Inc | 2 | $43 |
| Madrigal Pharmaceuticals | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: ENTYVIO, DUPIXENT, TREMFYA, IBSRELA, LINZESS, XIFAXAN, IQIRVO, Wegovy.
Industry payments across AZ — which companies pay providers there.
